Cronos Group Inc vs Franklin FTSE South Korea ETF — how do they compare? Cronos Group Inc trades at $3.22 (market cap $1.18B), while Franklin FTSE South Korea ETF trades at $58.19 (market cap $1.83B). The key difference: Franklin FTSE South Korea ETF is the larger of the two by market cap, and Cronos Group Inc is more actively traded (968,037 versus 679,902). Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Franklin FTSE South Korea ETF for 16 Days on average.
| CRON | FLKR | |
|---|---|---|
Market Cap | $1.18B | $1.83B |
Volume | 968,037 | 679,902 |
Sector | Health | Broad Market / Factor |
52-Week High | $3.55 | $72.25 |
52-Week Low | $2.30 | $27.09 |
Typical Hold Time | 22 Days | 16 Days |
Enterprise Value | $387.62M | — |
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.22, down 0.62% on the day, with a bearish technical signal and neutral oscillators. Revenue grew to $146.59M in 2025, but net income was -$9.45M. Recent Q2 2026 earnings beat expectations with EPS of $0.09. The company held its first Investor Day in September 2026, highlighting international expansion and cash flow focus.
Outlook is mixed: strong revenue growth and a solid balance sheet with no debt support upside, but profitability remains inconsistent. Risks include cash flow volatility and competitive pressures. Analyst consensus is cautious with 60% hold ratings, reflecting uncertainty amid expansion efforts.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →Franklin FTSE South Korea ETF seeks to track an index of South Korean equities. The fund provides exposure to companies listed in South Korea across multiple sectors.
Read more on FLKR →